US open Futures mixed as stimulus approved yields rise
Joe Biden signs $1.9 trillion stimulus package and pledges all adult Americans will be vaccinated by 1 May. Economic recovery expectations & treasury yields rise. Dow and Dollar aim higher, tech wreck resumes.
Share this:
US futures
Dow futures +0.2% at 32557
S&P futures -0.2% at 3927
Nasdaq futures -1.2% at 12890
In Europe
FTSE +0.1% at 6742
Dax -0.65% at 14480
Euro Stoxx -0.4% at 3828
Learn more about trading indices
Biden signs off on $1.9 trillion stimulus & vaccine drive
President Biden signed off on the largest fiscal stimulus bill in US history at the same time as pledging an acceleration to the vaccine drive.
Biden promised that all Americans would have the covid vaccine by 1 May to enable to return to normal life by 4 July Independence Day.
Combined, the stimulus and the vaccination pledge are driving economic recovery expectations and inflation expectations higher once again.
US 10 year yields which had dropped below 1.5% on Wednesday are now back over 1.60% taking the shine off stocks which boosting the US Dollar.
Stocks point to a mixed open
US stocks are pointing to a mixed start. The more cyclical Dow Jones is looking to extend gains into the weekend as the drive for value intensifies. The tech heavy Nasdaq is bracing itself for a deep selloff. Rising treasury yields are once again raising questions over lofty growth stock valuation. Meanwhile the tech sector in the S&P is dragging on the index.
Stocks in focus :
Tesla -2.9% pre-market after a fire at the electric car makers factory in California. The were no injuries and the fire in now under control. However it will have set back production at a time when rivals are ramping up.
Docusign -4% pre-market despite reporting forecast beating Q4 results and an upbeat guidance. The stock has surged 200% across the past 12 months.
Where next for Docusign share price?
Despite surging 200% over the past 12 months, the rally started to lose momentum from October. The share price traded within an ascending channel which it broke out from in early March.
The stock sold off sharply as part of the broader tech rout before finding a floor at 185p.
The stocks trades below its 50 & 20 sma – a negative bias. Support can be seen at 200 round number ahead of 187.00.
Any attempt to further the recovery would need to break through 240 for more buyers to jump in.
Vaccine developments: AstraZeneca & Novavax
AstraZeneca’s share price is holding up considerably well considering that the number of countries that. The stocks trades -0.5% as more and more countries in Europe halts the use of the vaccine amid fears that it is linked to blood clotting.
Novavax +16% pre-market has reported that its covid vaccine is 96% effective in late trials against the original covid strain. It was also 86% effective against the British strain. The stock rallied over 8% in the previous session & trades firmly higher pre-market.
FX – ECB stays pat on rates, PEPP purchases to ramp up
The US Dollar is rebounding from yesterday’s selloff, tracing US treasury yields higher. DXY trades +0.4% at 91.80.
GBP/USD trades lower after data revealed UK economy contracted -2.9% in January vs 1.2% growth in December. Exports to the EU also plunged 40% in the month following Brexit.
GBP/USD trades -0.6% at 1.3903
EUR/USD trades -0.35% at 1.1929
Oil calms after jumping on Thursday
After some big swings through the week, oil is heading into the weekend approximately flat.
Oil prices jumped 2.4% on Thursday, boosted by Joe Biden signing off on the $1.9 trillion stimulus package in US and his pledge to vaccinate all American adults by the start of May. Future oil demand expectations rose in line with expectations of a much quicker US recovery.
OPEC revealed in its monthly report a downward revision in oil demand in the first half of the year, making last week’s OPEC+ group’s decision less surprising. OPEC also upwardly revised its demand estimates for H2.
Baker Hughes rig count data is due later today.
US crude trades +0.02% at $65.94
Brent trades -0.1% at $69.25
Learn more about trading oil here.
The complete guide to trading oil markets
Looking ahead
14:00 Canadian Jobs Data
15:00 Michigan Consumer Confidence
18:00 Baker Hughes Rig Count
Fiona Cincotta looks at the price action and levels to watch in USD/CAD
US futures
Dow futures +0.2% at 32557
S&P futures -0.2% at 3927
Nasdaq futures -1.2% at 12890
In Europe
FTSE +0.1% at 6742
Dax -0.65% at 14480
Euro Stoxx -0.4% at 3828
Learn more about trading indices
Biden signs off on $1.9 trillion stimulus & vaccine drive
President Biden signed off on the largest fiscal stimulus bill in US history at the same time as pledging an acceleration to the vaccine drive.
Biden promised that all Americans would have the covid vaccine by 1 May to enable to return to normal life by 4 July Independence Day.
Combined, the stimulus and the vaccination pledge are driving economic recovery expectations and inflation expectations higher once again.
US 10 year yields which had dropped below 1.5% on Wednesday are now back over 1.60% taking the shine off stocks which boosting the US Dollar.
Stocks point to a mixed open
US stocks are pointing to a mixed start. The more cyclical Dow Jones is looking to extend gains into the weekend as the drive for value intensifies. The tech heavy Nasdaq is bracing itself for a deep selloff. Rising treasury yields are once again raising questions over lofty growth stock valuation. Meanwhile the tech sector in the S&P is dragging on the index.
Stocks in focus :
Tesla -2.9% pre-market after a fire at the electric car makers factory in California. The were no injuries and the fire in now under control. However it will have set back production at a time when rivals are ramping up.
Docusign -4% pre-market despite reporting forecast beating Q4 results and an upbeat guidance. The stock has surged 200% across the past 12 months.
Where next for Docusign share price?
Despite surging 200% over the past 12 months, the rally started to lose momentum from October. The share price traded within an ascending channel which it broke out from in early March.
The stock sold off sharply as part of the broader tech rout before finding a floor at 185p.
The stocks trades below its 50 & 20 sma – a negative bias. Support can be seen at 200 round number ahead of 187.00.
Any attempt to further the recovery would need to break through 240 for more buyers to jump in.
Vaccine developments: AstraZeneca & Novavax
AstraZeneca’s share price is holding up considerably well considering that the number of countries that. The stocks trades -0.5% as more and more countries in Europe halts the use of the vaccine amid fears that it is linked to blood clotting.
Novavax +16% pre-market has reported that its covid vaccine is 96% effective in late trials against the original covid strain. It was also 86% effective against the British strain. The stock rallied over 8% in the previous session & trades firmly higher pre-market.
FX – UK GDP -2.9% MoM
The US Dollar is rebounding from yesterday’s selloff, tracing US treasury yields higher. DXY trades +0.4% at 91.80.
GBP/USD trades lower after data revealed UK economy contracted -2.9% in January vs 1.2% growth in December. Exports to the EU also plunged 40% in the month following Brexit.
GBP/USD trades -0.6% at 1.3903
EUR/USD trades -0.35% at 1.1929
Oil ends the week on a calm note
After some big swings through the week, oil is heading into the weekend approximately flat.
Oil prices jumped 2.4% on Thursday, boosted by Joe Biden signing off on the $1.9 trillion stimulus package in US and his pledge to vaccinate all American adults by the start of May. Future oil demand expectations rose in line with expectations of a much quicker US recovery.
OPEC revealed in its monthly report a downward revision in oil demand in the first half of the year, making last week’s OPEC+ group’s decision less surprising. OPEC also upwardly revised its demand estimates for H2.
Baker Hughes rig count data is due later today.
US crude trades +0.02% at $65.94
Brent trades -0.1% at $69.25
Learn more about trading oil here.
The complete guide to trading oil markets
Looking ahead
14:00 Canadian Jobs Data
15:00 Michigan Consumer Confidence
18:00 Baker Hughes Rig Count
Fiona Cincotta looks at the price action and levels to watch in USD/CAD here
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
Japanese Yen Forecast: USD/JPY 4% Rally Challenges Post-Intervention Downtrend 9 24 2026
USD/JPY momentum has shifted sharply higher, putting a major resistance confluence in focus as U.S. and Japanese event risk builds.
Oil Quietly Hands the Fed a Reason to Stay Hawkish
Oil prices and the U.S. dollar are both on the front foot as elevated energy costs feed Fed warnings that inflation may prove sticky.
S&P 500 forecast: Stocks extend drop as correction risks grow
US and global equity markets have extended Wednesday’s sell-off, with Wall Street opening lower after a weak handover from Asia and Europe. The deterioration in risk appetite has been spreading across global markets. The dollar was firmer, Treasury yields were holding onto yesterday’s gains, while gold, silver and bitcoin were all under pressure alongside equities and major currencies.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.